文献速递心脑血管急症复苏、休克与脓毒症重症综合管理与镇静镇痛

患者与医疗服务因素及急性冠脉综合征院外心脏骤停复苏后院内死亡率变异:心肌缺血国家审计项目分析

Patient, health service factors and variation in mortality following resuscitated out-of-hospital cardiac arrest in acute coronary syndrome: Analysis of the Myocardial Ischaemia National Audit Project.
PubMed 文献 · Resuscitation · 2018-01-05
一句话结论急性冠脉综合征导致的院外心脏骤停复苏后,院内死亡率28.7%,医院间变异大(10.7%–66.3%),STEMI早期再灌注治疗与较低死亡率相关。

该队列研究利用英国心肌缺血国家审计项目数据库,纳入2003至2015年间因急性冠脉综合征导致院外心脏骤停复苏后住院的17604例患者,覆盖239家医院。总体院内死亡率为28.7%,在至少收治60例的94家医院中,死亡率范围为10.7%至66.3%(中位数28.6%,IQR 23.2%–39.1%)。患者与医疗服务因素仅解释36.1%的医院间变异。校正协变量后,与较高院内死亡率相关的因素包括血糖升高、ST段抬高型心肌梗死诊断以及初始入住具备直接经皮冠状动脉介入治疗能力的医院;医院院外心脏骤停收治量未与死亡率相关。STEMI患者早期再灌注治疗是与较低死亡率相关的关键可干预因素。

要点

  • 急性冠脉综合征导致的院外心脏骤停复苏后住院患者总体院内死亡率为28.7%(17604例,239家医院)。
  • 至少收治60例的94家医院间死亡率变异大,范围10.7%–66.3%,中位数28.6%(IQR 23.2%–39.1%)。
  • 患者与医疗服务因素仅解释36.1%的医院间死亡率变异。
  • 校正后,血糖升高、STEMI诊断及初始入住具备pPCI能力的医院与较高院内死亡率相关;医院OHCA收治量未与死亡率相关。
  • STEMI患者早期再灌注治疗是与较低院内死亡率相关的关键可干预因素。

适用人群与场景

  • 2003至2015年间英国因急性冠脉综合征导致院外心脏骤停、经复苏后住院的患者,共17604例,来自239家医院。

研究设计与关键结果

  • 研究类型为队列研究,使用心肌缺血国家审计项目数据库,纳入17604例患者,覆盖239家医院;总体院内死亡率为28.7%。
  • 在至少收治60例的94家医院中,院内死亡率范围为10.7%至66.3%,中位数28.6%(IQR 23.2%–39.1%)。
  • 患者与医疗服务因素共解释36.1%的医院间死亡率变异。
  • 校正协变量后,与较高院内死亡率相关的因素包括血糖升高、STEMI诊断以及初始入住具备直接经皮冠状动脉介入治疗能力的医院。
  • 医院院外心脏骤停收治量与死亡率无关。
  • STEMI患者早期再灌注治疗是与较低院内死亡率相关的关键可干预因素。

证据类型、等级与局限

  • 证据类型:队列研究(基于心肌缺血国家审计项目数据库)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于急性冠脉综合征导致的院外心脏骤停复苏后患者,STEMI患者早期再灌注治疗与较低院内死亡率相关(作者结论)。
  • 医院院外心脏骤停收治量和pPCI能力未与较低死亡率相关,不应仅以收治量或pPCI能力判断医院救治水平(作者结论)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIMS: To determine patient and health service factors associated with variation in hospital mortality among resuscitated cases of out-of-hospital cardiac arrest (OHCA) with acute coronary syndrome (ACS).

METHODS: In this cohort study, we used the Myocardial Ischaemia National Audit Project database to study outcomes in patients hospitalised with resuscitated OHCA due to ACS between 2003 and 2015 in the United Kingdom. We analysed variation in inter-hospital mortality and used hierarchical multivariable regression models to examine the association between patient and health service factors with hospital mortality.

RESULTS: We included 17604 patients across 239 hospitals. Overall hospital mortality was 28.7%. In 94 hospitals that contributed at least 60 cases, mortality by hospital ranged from 10.7% to 66.3% (median 28.6%, IQR 23.2% to 39.1%)). Patient and health service factors explained 36.1% of this variation. After adjustment for covariates, factors associated with higher hospital mortality included increasing serum glucose, ST-Elevation myocardial infarction (STEMI) diagnosis, and initial admission to a primary percutaneous coronary intervention (pPCI) capable hospital. Hospital OHCA volume was not associated with mortality. The key modifiable factor associated with lower mortality was early reperfusion therapy in STEMI patients.

CONCLUSION: There was wide variation in inter-hospital mortality following resuscitated OHCA due to ACS that was only partially explained by patient and health service factors. Hospital OHCA volume and pPCI capability were not associated with lower mortality. Early reperfusion therapy was associated with lower mortality in STEMI patients.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Couper K, Kimani PK, Gale CP, et al. Patient, health service factors and variation in mortality following resuscitated out-of-hospital cardiac arrest in acute coronary syndrome: Analysis of the Myocardial Ischaemia National Audit Project. Resuscitation. 2018. PMID: 29309882. doi:10.1016/j.resuscitation.2018.01.011

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。